Education
About Us
Working with TipRanks
Follow Us
Stryker Corporation (SYK)
NYSE:SYK
SYK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$314.93 - $406.19
Previous CloseN/A
Volume378.36K
Average Volume (3M)1.90M
Market Cap
$133.70B
Enterprise Value$148.64B
Total Cash (Recent Filing)$1.20B
Total Debt (Recent Filing)$996.20M
Price to Earnings (P/E)45.1
Beta0.62
Next Earnings
May 01, 2025EPS Estimate
2.71Last Dividend Ex-Date
Mar 31, 2025Dividend Yield0.94%
Share Statistics
EPS (TTM)7.76
Shares Outstanding381,688,840
10 Day Avg. Volume2,598,676
30 Day Avg. Volume1,895,828
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)N/A
Price to Sales (P/S)6.27
Price to Cash Flow (P/CF)18.30
P/FCF Ratio15.20
Enterprise Value/Market Cap1.11
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.29
Enterprise Value/Ebitda26.00
Forecast
1Y Price Target
$434.15Price Target Upside22.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
---
Bulls Say, Bears Say
Bulls Say
Business MomentumSYK entered 2025 with strong business momentum, continuing elevated procedural growth and a robust capital order book.
Innovation And GrowthSYK's strategic decision to divest its US spine business reflects its commitment to invest in innovation and areas with better growth potential.
Robotic AdvancementsThese innovations highlight Stryker's continued global leadership and commitment to orthopedic robotic advancements.
Strategic DivestitureThe proposed divestiture is seen as a positive move as it allows SYK to focus on higher growth segments and areas where it has a competitive advantage.
Bears Say
Earnings ImpactThe deal would be dilutive to its operating margin by 0-20 bps and dilutive to its 2025 EPS by $0.20-0.30.
Revenue DeclineThe decline in SYK's global spinal implants business revenue was primarily due to a decrease in the US market.
---
Ownership Overview
4.64% Insiders
22.26% Mutual Funds
22.95% Other Institutional Investors
32.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SYK FAQ
What was Stryker Corporation’s price range in the past 12 months?
Stryker Corporation lowest stock price was $314.93 and its highest was $406.19 in the past 12 months.
What is Stryker Corporation’s market cap?
Stryker Corporation’s market cap is $133.70B.
When is Stryker Corporation’s upcoming earnings report date?
Stryker Corporation’s upcoming earnings report date is May 01, 2025 which is in 16 days.
How were Stryker Corporation’s earnings last quarter?
Stryker Corporation released its earnings results on Jan 28, 2025. The company reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.872 by $0.138.
Is Stryker Corporation overvalued?
According to Wall Street analysts Stryker Corporation’s price is currently Undervalued.
Does Stryker Corporation pay dividends?
Stryker Corporation pays a Quarterly dividend of $0.839 which represents an annual dividend yield of 0.94%. See more information on Stryker Corporation dividends here
What is Stryker Corporation’s EPS estimate?
Stryker Corporation’s EPS estimate is 2.71.
How many shares outstanding does Stryker Corporation have?
Stryker Corporation has 381,688,840 shares outstanding.
What happened to Stryker Corporation’s price movement after its last earnings report?
Stryker Corporation reported an EPS of $4.01 in its last earnings report, beating expectations of $3.872. Following the earnings report the stock price went down -1.032%.
Which hedge fund is a major shareholder of Stryker Corporation?
Currently, no hedge funds are holding shares in SYK
---
Stryker Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$434.15 (22.84% Upside)
$434.15 (22.84% Upside)
Blogger Sentiment
Bullish
SYK Sentiment 84%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 601.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $79.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.08%
12-Months-Change
Fundamentals
Return on Equity
15.26%
Trailing 12-Months
Asset Growth
7.66%
Trailing 12-Months
Company Description
Stryker Corporation
Stryker Corporation is a leading global medical technology company headquartered in Kalamazoo, Michigan. The company operates across three main sectors: Orthopedics, MedSurg, and Neurotechnology and Spine. Stryker's core products and services include a wide array of medical devices, surgical equipment, and innovative technologies aimed at improving patient care. The company is committed to advancing healthcare through the development of high-quality, cutting-edge solutions that address the needs of healthcare providers and patients worldwide.
---
SYK Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong performance and growth across multiple segments, driven by successful product launches and strategic acquisitions. Despite challenges in the Spinal Implants business and foreign currency impacts, the company's robust operating margin expansion and high growth in key areas suggest positive momentum going into 2025.Read More>---
SYK Net sales Breakdown
59.83% MedSurg and Neurotechnology
40.17% Orthopaedics and Spine
---
SYK Stock 12 Month Forecast
Average Price Target
$434.15
▲(22.84% Upside)
Technical Analysis
Abbott Labs
―
Boston Scientific
―
Edwards Lifesciences
―
Medtronic
―
Zimmer Biomet Holdings
―
Best Analysts Covering SYK
1 Year
1 Year Success Rate
13/16 ratings generated profit
1 Year Average Return
+13.06%
reiterated a buy rating last month
Copying Shagun Singh Chadha's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +13.06% per trade.
---